$HSC RESOURCES (01850.HK)$ Is there a chance for this stock to bounce back?
Translated
6
$HSC RESOURCES (01850.HK)$ $WINDMILL GP(01850)$ scammer alert... The same scammer by the name of Ernest chan is coming out to scam again.. this time he's using telegram to gather victims.. promise 200 percent upside kn his recommendation...pls take note
3
4
11
4
tomy tan
reacted to
By Julianna
Investors appear to be losing patience with Ark Investment Management's genomics fund.
$ARK Genomic Revolution ETF (ARKG.US)$ is an actively managed ETF that focus on health care, information technology, materials, energy, and consumer discretionary.
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
- according to ARKG fund description.
However, ARKG is down 30% this year as investors shun health-care stocks in favor for more cyclical names that perform well during an economic recovery. Even so, this ETF is faring far worse than the broader biotech sector, with the $Dow Jones U.S. Biotechnology Index (.DJUSBT.US)$up 11.35% this year.
ARKG is currently trading at $65.16 a share, 43% lower from its peak in this February. The genomics fund has also seen the largest outflows among Ark's ETFs this year.
It's interesting that typically loyal Ark investors have been bailing on the ETF.
The fund's assets have been chopped in half since February. While I don't believe the ETF is experiencing some of sort of 'doom loop,' clearly the outflows are putting downward price pressure on the underlying holdings and testing the will of remaining fund owners.
- said Nate Geraci, president of The ETF Store, an advisory firm.
FOLLOW ME to know more about ETFs
PLZ leave your comments and likes below
ARKG's top two holdings, $Teladoc Health (TDOC.US)$and $Exact Sciences (EXAS.US)$, heavily impact its performance, with drops of 47% and 33.5% this year, respectively.
The recent outflows may be due to investors looking for shorter-term opportunities into the year-end and freeing up cash.
- said Sylvia Jablonski, chief investment officer at Defiance ETFs.
Ark Chief Executive Officer Cathie Wood is well-known for prioritizing longer term investments over short-term gains.
This is a 5-10 year hold. AI in health care is going to change the way that we can predict, treat and manage the most difficult diseases like cancer, and the Ark fund gives investors access to the companies who are on the cutting edge of that research.
- Jablonski added.
Have you ever invested in the Biotechnology sector? Do you agree with Jablonski's opinion?
Source: Bloomberg
Investors appear to be losing patience with Ark Investment Management's genomics fund.
$ARK Genomic Revolution ETF (ARKG.US)$ is an actively managed ETF that focus on health care, information technology, materials, energy, and consumer discretionary.
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
- according to ARKG fund description.
However, ARKG is down 30% this year as investors shun health-care stocks in favor for more cyclical names that perform well during an economic recovery. Even so, this ETF is faring far worse than the broader biotech sector, with the $Dow Jones U.S. Biotechnology Index (.DJUSBT.US)$up 11.35% this year.
ARKG is currently trading at $65.16 a share, 43% lower from its peak in this February. The genomics fund has also seen the largest outflows among Ark's ETFs this year.
It's interesting that typically loyal Ark investors have been bailing on the ETF.
The fund's assets have been chopped in half since February. While I don't believe the ETF is experiencing some of sort of 'doom loop,' clearly the outflows are putting downward price pressure on the underlying holdings and testing the will of remaining fund owners.
- said Nate Geraci, president of The ETF Store, an advisory firm.
FOLLOW ME to know more about ETFs
PLZ leave your comments and likes below
ARKG's top two holdings, $Teladoc Health (TDOC.US)$and $Exact Sciences (EXAS.US)$, heavily impact its performance, with drops of 47% and 33.5% this year, respectively.
The recent outflows may be due to investors looking for shorter-term opportunities into the year-end and freeing up cash.
- said Sylvia Jablonski, chief investment officer at Defiance ETFs.
Ark Chief Executive Officer Cathie Wood is well-known for prioritizing longer term investments over short-term gains.
This is a 5-10 year hold. AI in health care is going to change the way that we can predict, treat and manage the most difficult diseases like cancer, and the Ark fund gives investors access to the companies who are on the cutting edge of that research.
- Jablonski added.
Have you ever invested in the Biotechnology sector? Do you agree with Jablonski's opinion?
Source: Bloomberg
+1
128
25
tomy tan
liked
$AMC Entertainment (AMC.US)$
The whole idea up to this point was that when they cover they have to keep buying until they hit real shares.
Lou now says they are using our buying to dilute the stock.
That derails the whole thesis of buy and hold, IF THEY MUST HAVE REAL SHARES TO COVER.
So if they can get us to give up and start selling, being that we own the float yadda yadaa, then they will get thier hands on the shares they need realy fast.
I say ya stop buying. It's time. Now hold and plan to contiue to hold, oh lets say for about 2 more months
Dec and Jan, and lets just sit back HOLD and watch what they do.
They need us to get confused. That's the game. HOLD... STOP BUYING THEIR IOU'S AND HOLD....
The whole idea up to this point was that when they cover they have to keep buying until they hit real shares.
Lou now says they are using our buying to dilute the stock.
That derails the whole thesis of buy and hold, IF THEY MUST HAVE REAL SHARES TO COVER.
So if they can get us to give up and start selling, being that we own the float yadda yadaa, then they will get thier hands on the shares they need realy fast.
I say ya stop buying. It's time. Now hold and plan to contiue to hold, oh lets say for about 2 more months
Dec and Jan, and lets just sit back HOLD and watch what they do.
They need us to get confused. That's the game. HOLD... STOP BUYING THEIR IOU'S AND HOLD....
39
7
tomy tan
liked
$Camber Energy (CEI.US)$ Good night all 😴😴
Translated
1
tomy tan
liked
$Camber Energy (CEI.US)$Today, the institution once again followed the post-market route.
Translated
9